Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04982653 · ClinicalTrials.gov registry record · Phase 2
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
A Phase 2 study of Metastatic Malignant Neoplasm in the Liver and Primary Malignant Liver Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT04982653 is a Phase 2 study of Metastatic Malignant Neoplasm in the Liver and Primary Malignant Liver Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 140 participants, above the 81-participant average among 13 other Metastatic Malignant Neoplasm in the Liver trials with a reported enrollment target (73% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04982653, a Phase 2 study of Metastatic Malignant Neoplasm in the Liver and Primary Malignant Liver Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an abdominal hernia) at the incision site better than the other.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Surgical Procedure
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2026-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04982653
The ClinicalTrials.gov registry entry for NCT04982653 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 81-participant average among 13 other Metastatic Malignant Neoplasm in the Liver trials with a reported enrollment target (73% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Metastatic Malignant Neoplasm in the Liver appearing as the primary indexed condition, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04982653 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04982653 about?
NCT04982653 is a clinical study titled "Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy". This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an...
What is the current status of trial NCT04982653?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2022-01-04. Estimated completion is 2026-04-30.
What conditions does trial NCT04982653 study?
This clinical trial studies the following conditions: Metastatic Malignant Neoplasm in the Liver, Primary Malignant Liver Neoplasm, Liver and Intrahepatic Bile Duct Neoplasm.
What interventions are being tested in trial NCT04982653?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Surgical Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT04982653?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04982653 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Neoplasm in the Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RECRUITING · Phase 2
-
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
ACTIVE NOT RECRUITING · Phase 2
-
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases
ACTIVE NOT RECRUITING · Phase 2
-
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
RECRUITING · Phase 1
-
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
RECRUITING · Phase 1
-
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
RECRUITING · NA
Explore more on PlainTrial
Metastatic Malignant Neoplasm in the Liver
All registered trials for this condition
Primary Malignant Liver Neoplasm
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.